http://www.oxford-instruments.com/Pages/home.aspx


Oxford Instruments is a leading provider of high technology tools and systems for research and industry. We design and manufacture equipment that can fabricate, analyse and manipulate matter at the atomic and molecular level.

Oxford Instruments has discrete business groups operating in three sectors. This means we can focus our expertise, our technologies and our innovation on offering our customers high quality products and service that meet their stringent requirements.







Financial Calendar


Half Year/Interim Results Announcement

Tuesday November 13th 2012 : 9.30am The London Stock Exchange

Annual General Meeting:

Tuesday 11th September 2012 : 2.30pm

Oxford Instruments plc, Tubney Woods, Abingdon, Oxon OX13 4QX

26 September 2012 Ordinary shares quoted ex-dividend
28 September 2012 Record date for final dividend
30 September 2012 DRIP date
25 October 2012 Payment of final dividend
March 2013 Ordinary shares quoted ex-dividend
Dividend reinvestment (DRIP) last date for election
Record date for interim dividend
31 March 2013 Financial Year End

Is it time to invest in Digital Britain? Five top technology shares to rival Twitter

By Marc Shoffman

PUBLISHED: 15:50, 15 November 2013 | UPDATED: 15:50, 15 November 2013


Oxford Instruments


Price-to-earnings ratio: 36.37


Dividend yield: 0.81 per cent


Share price as of 13 November: 1,462.00p

Most recent profits: £22m (31 March 2012)


The first technology business to be spun out from Oxford University over forty years ago, Oxford Instruments creates technology products for research


It was started in the garden shed of Sir Martin Wood in Oxford in 1959 to build superconducting magnets for scientific research. It got backing from Oxford University and listed in 1983.

The company’s best known projects include manufacturing the first commercial MRI scanner.


Mr Mould says: ‘Oxford Instruments’ business model sees high-tech equipment sold into nanotechnology and industrial markets across the globe, and increasingly to Far East markets keen to expand their technological and scientific research base. This provides a vast and growing installed base from which after-sales parts and service revenues stem, generating highly visible and rising revenues.


‘The company prides itself on turning smart science and innovation into commercially successful products, raising the barriers to entry for new competitors. Research spending cuts in Europe and the US have temporarily slammed the brakes on yet Oxford insists it remains on target to match its ’14 Cubed’ objectives of 14 per cent average revenue growth and return on sales, by 2014.'





http://www.dailymail.co.uk/money/investing/article-2505169/Five-UK-technology-stocks-rival-Twitter.html

Update on Possible Offer for Andor Technology plc

RNS


RNS Number : 0991U

Oxford Instruments PLC

27 November 2013






NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION



This is an announcement falling under Rule 2.4 of the City Code on Takeovers and Mergers (the "Code") and does not constitute an announcement of a firm intention to make an offer or to pursue any other transaction under Rule 2.7 of the Code. Accordingly, Andor Technology plc shareholders are advised that there can be no certainty that a formal offer for Andor Technology plc will be forthcoming, even in the event that the pre-conditions in this announcement are satisfied or waived.







27 November 2013





Oxford Instruments plc - Update on Possible Offer for Andor Technology plc



On 12 November 2013, Oxford Instruments plc ("Oxford Instruments" or the "Company") announced that it was in discussions with Andor Technology plc ("Andor") in relation to a possible offer for Andor.

Following the provision of further information including a meeting yesterday between senior management, Oxford Instruments announces that it has now completed its outstanding due diligence and has confirmed to the Board of Andor its proposed offer of 500 pence per share in cash to acquire the entire issued and to be issued share capital of Andor.

The making of any offer remains subject to the following pre-conditions:

i. the unanimous and unqualified recommendation by the Board of Andor in respect of any offer by Oxford Instruments; and

ii. the Directors of Andor giving irrevocable undertakings to accept any offer in respect of all of the Andor shares in which they are interested.

Oxford Instruments reserves the right to waive any or all of the pre-conditions described in this announcement. Even if all of these pre-conditions are satisfied or waived, there can be no certainty that a firm offer will be forthcoming.

Facilities to allow Oxford Instruments to provide certain funds in support of the offer have been negotiated and can be executed at short notice.

Further, Oxford Instruments reserves the right to make an offer on less favourable terms than those set out in this announcement in the event that:

i. Andor announces, declares, pays or makes any dividend or distribution to Andor shareholders at any time, in which case there will be an equivalent reduction in Oxford Instruments' offer price; or

ii. the issued and to be issued share capital of Andor is greater than the 33.2 million shares that has been assumed, such that the pro rata entitlement per Andor share is lower than 500 pence.

Rule 2.6(a) of the Code, requires that Oxford Instruments, by not later than 5.00 p.m. on 10 December2013 (the "relevant deadline"), either announces a firm intention to make an offer for Andor in accordance with Rule 2.7 of the Code or announces that it does not intend to make an offer, in which case the announcement will be treated as a statement to which Rule 2.8 of the Code applies. This deadline can be extended with the consent of the Takeover Panel in accordance with Rule 2.6(c) of the Code.

MIDAS SHARE TIPS UPDATE: Oxford Instruments recommendation sparks another following 774% rise

By Joanne Hart, Financial Mail On Sunday

PUBLISHED: 22:28, 21 December 2013 | UPDATED: 22:28, 21 December 2013

Oxford Instruments has grown from a small, academic business into a highly successful company valued on the stock market at almost £1billion.

Spun out of Oxford University, the stock was first recommended by Midas six years ago, in December 2007. At that time, the shares were 195p and the company was under pressure.


Today, the stock is 1705p and has just agreed a £176 million takeover of Andor Technology, another Midas recommendation (tipped at 5041⁄2p in April 2012, now 525p).





Innovative: The company's research led to the creation of MRI scanners


Oxford Instruments traces its roots back to 1959, when husband and wife team Martin and Audrey Wood developed the world’s first superconducting magnet, which led to the invention of MRI scanners, used in hospitals around the world today.

The Woods founded Oxford Instruments from their garden shed in the city and although the company became known for the brilliance of its scientific team, commercial success proved elusive until Jonathan Flint was appointed chief executive in 2005 with finance director Kevin Boyd joining a year later.

Flint and Boyd have worked hard to blend Oxford Instruments’ scientific expertise with sales and profits growth and the results have been impressive.


Glowing: Oxford Instruments' discoveries are used in sun cream

The company’s technological know-how is used by industries around the world to make products ranging from sun cream to light bulbs to electronic gadgets.


It has even created a tool, called Pulsar, which looks at the chemical composition of meat to see whether it is what it says on the label or something more sinister, such as horsemeat.

Talks are ongoing with supermarket groups and the machine should prove very successful.

Flint is now keen to move into a sector known as nano-bio, which examines tiny particles within, for example, human cells, and uses that knowledge to develop cures for cancer or more resistant crops.


Oxford Instruments provides the tools to foster this research and the acquisition of specialist camera maker Andor will prove helpful in this area.


Andor’s equipment is among the best in the world, but the company has been affected as clients have cut back on research. Oxford Instruments’ 525p-a-share bid is a welcome move for Andor shareholders but it should benefit both companies over the next few years.


Midas verdict: Oxford Instruments shares have risen eight-fold over the past six years, testimony to Flint and Boyd’s drive and vision. Investors could sell up to 30 per cent of their stock and bank the cash, but hang on to their remaining stock as this company should deliver long-term growth.

Shares - Oxford aspires to new heights

Double-digit growth and acquisition synergies to keep shares moving


Shares in Oxford Instruments (OXIG) could fly as high as £21 once analysts settle on new forecasts in the wake of the firm’s recommended takeover of fellow scientific kit maker Andor Technology (AND:AIM).

The promise of a return to double-digit revenue growth should encourage the market to rethink Oxford’s valuation. Operational leverage means progress should be even faster at the profits line and the experts at Deutsche Bank believe operating synergies from the Andor deal will add even greater scope for profits progress as volume orders start to ramp up once more. The investment bank calculates 2% cost savings will be superceded by as much as 10% revenue synergies at the combined group. Deutsche estimates earnings per share (EPS) could jump 23% from 65.2p in 2014 to 80.4p by 2016.

Although the broker’s £21 price target implies a 26 times price/earnings multiple for three years’ time, barriers to entry, good returns on capital and strong earnings momentum could all support such an apparently lofty rating.

Buy

Double-digit revenues and operational gearing should combine to maintain the momentum behind Oxford’s shares and support the bullish consensus view at £16.89.

You must be in this one Stan. :-))

Oxford Instruments PLC (OXIG:LSE) set a new 52-week high during today's trading session when it reached 1,820. Over this period, the share price is up 23.03%.

Afraid not D/C, I called this one very wrong sadly, going great guns isn't it?

:-((

11 Feb JP Morgan... 1,750.00 Overweight

Pre-close Trading Update

RNS


RNS Number : 4651E

Oxford Instruments PLC

10 April 2014






Release Date: 10 April 2014





Pre-close Trading Update





Oxford Instruments plc, a leading provider of high technology tools and systems for industry and research, is today issuing a trading statement ahead of entering its close period.



As anticipated, there was a strong trading performance in the last quarter. The integration of Andor Technology is proceeding to plan and has aided the results; however this has been offset by the strength of sterling against our main trading currencies. As a result we reiterate the guidance given in our February IMS that we expect performance for the year to be in-line with the prior year.



Oxford Instruments' preliminary results for the year ended 31 March 2014 will be released on Tuesday 10 June.



Ends

Final results Tues 10 June

Final Results

RNS


RNS Number : 2050J

Oxford Instruments PLC

10 June 2014






Release Date: 7am Tuesday 10 June 2014



Oxford Instruments plc

Announcement of Preliminary Results for the year to 31 March 2014



Oxford Instruments plc, a leading provider of high technology tools and systems for industry and research, today announces its Preliminary Results for the year to 31 March 2014.



Highlights:



· Orders grew by 2.5% to £342.2 million (2013: £334.0 million)

· Revenue grew by 2.7% to £360.1 million (2013: £350.8 million); 4.3% on a constant currency basis

· Adjusted profit before tax* of £47.1 million (2013: £47.0 million)

· Adjusted operating margin* of 14.0% (2013: 14.1%), in line with 14 Cubed objectives

· Adjusted EPS* up 1.8% at 67.7 pence (2013: 66.5 pence)

· Andor Technology acquisition integrating well and performing ahead of plan

· Investment in R&D, up 11.2% to £27.9 million (2013: £25.1 million)

· Proposed final dividend of 9.04 pence (2013: 8.15 pence), giving a total dividend for the year of 12.4 pence (2013: 11.2 pence)

· Strategy seeks to exploit the convergence of the sciences which will enhance demand for nanotechnology tools

*Adjusted numbers are stated to give a better understanding of the underlying business performance. Details of adjusting items can be found in Note 1.



Jonathan Flint, Chief Executive of Oxford Instruments plc, said:



"The Group delivered another successful result, with orders, sales and profits all ahead of the prior year. We are very pleased to welcome Andor to Oxford Instruments and see the acquisition as an important part of the next phase of our growth.



We will continue to focus on developing innovative new products and growing market share in our core areas of physical science. In addition, we will seek to extend our reach into adjacent new markets by applying our tools and technologies to life science research and analysis.



This convergence of the sciences will enhance long term demand for our nanotechnology tools and enable us to reach a new set of customers working in the nano-bio arena."

11 Jun JP Morgan... 1,750.00 Overweight

16 Jun N+1 Singer 1,445.00 Hold

Share tips: 'Why I am backing Oxford Instruments'

Each week we look at a promising mid-cap share. This week: Oxford Instruments, which makes hi-tech equipment for scientific research

Part Of The Atlas Experiment Equipment: How the universe evolved from a liquid

Oxford Instruments only makes around 9pc of its revenue in the UK, making it vulnerable to the strength of the pound Photo: REX FEATURES


By Kyle Caldwell

6:13PM BST 03 Jul 2014




Oxford Instruments, which makes hi-tech equipment for scientific research, has suffered of late from a drop in demand from government-funded projects. But this has not led all investors to rush for the exits.


One fund manager who remains a fan is Chris Murphy, who runs the Aviva Investors UK Equity Income fund. He said that despite a 27pc fall in the share price this year he would remain a long-term holder.


“The firm has an unloved status following pressures of government spending cuts and the effects of a strong pound,” he said. “But having met with the firm last month I came away with the impression of a business turning a corner and a management team with a plan.”


The plan involves focusing on developing new products while keeping an eye on potential acquisitions to expand the business. Oxford Instruments has bought several firms in recent years, the latest being Andor Technology, which it bought for £158m in January.


“The firm’s market-leading products mean that the shares continue to justify premium pricing relative to peers,” Mr Murphy said.


“An improving global outlook should see a return to research funding, while issues such as the horsemeat scandal have led to a dramatic increase in food testing and the need for better technology.”

Interim Management Statement

RNS


RNS Number : 3969M

Oxford Instruments PLC

16 July 2014






Release date: 16 July 2014



Oxford Instruments plc

Interim Management Statement





Oxford Instruments plc, a leading provider of high technology tools and systems for industry and research, today issues an Interim Management Statement which covers the period from 1 April 2014 to date.

Orders in the first quarter of the year were above the same period last year despite the worsening foreign exchange environment. This was on both a reported and constant currency organic basis.

On a constant currency basis, orders were ahead of the same period last year in our major trading regions of Europe, North America and Asia. Excluding Andor, acquired in January 2014, orders were ahead in North America but lagged in Europe and Asia.

The integration of Andor continues to progress and its performance was slightly ahead of expectations in the first three months of the year.

Our broad spread of geographies and technologies and our strong pipeline of new products continue to underpin the long term prospects for the Group. The Board anticipates that Oxford Instruments will continue to make progress in line with its expectations for the remainder of the financial year.

Save as described in this statement, there has been no significant change in the financial position of the Group in the period.

Beaufort Securities - Oxford Instruments (LOL:OXIG)

Yesterday, Oxford Instruments announced that it expects an enhanced second half owing to better year to date order intake compared to the previous year on a reported and constant currency basis. The company concluded its 14Cubed plan in June and realized a return of 14% on sales and an annually compounded revenue increase of 11% over a period of three years. The successful integration with Andor, acquired in January this year, also helped strengthen the order book in North America and Europe for nanotechnology tools and industrial products. On a separate note, the company announced the retirement of Sir Michael Brady and the appointment of Sir Richard Friend to the board. The stock rose 3.1% in yesterday’s trade.

Our view: The improved order book of Oxford Instruments is well indicative of the robust revenues that could be achieved by the company in this fiscal. Barring a few hiccups from the Asian markets, the company expects to leverage its brand equity and distribution network in the ever expanding market for its products. Oxford Instruments continued efforts to enhance operational efficiencies to focus on convergence of the nano-bio sciences along with strategic acquisitions give the company a good upside potential. We retain a Buy rating for the stock.

Shares - We see scope to surprise on the upside as conditions improve into 2015.

13 Oct Investec 1,405.00 Buy

Interim results Tues 11 Nov